Cogent Biosciences, Inc. (COGT)
31.98
+0.82
(+2.63%)
USD |
NASDAQ |
Jun 09, 16:00
31.98
0.00 (0.00%)
After-Hours: 18:07
Cogent Biosciences Total Assets (Quarterly) : 903.01M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vera Therapeutics, Inc. | 621.74M |
| Replimune Group, Inc. | 333.59M |
| Vir Biotechnology, Inc. | 1.026B |
| Revolution Medicines, Inc. | 2.254B |
| Vaxcyte, Inc. | 3.348B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 295.31M |
| Shareholders Equity (Quarterly) | 607.69M |
| Debt to Equity Ratio | 0.3927 |
| Current Ratio | 15.14 |
| Net Debt Paydown Yield | -0.67% |